Empowering value-based oncology care: the ONCOVALUE project

Written by The Evidence Base

Five projects, part of the MetReal cluster, have received funding from the European Union and over a 4- to 5-year period will seek to explore, “New methods for the effective use of real-world data (RWD) and/or synthetic data in regulatory decision-making and/or in health technology assessment.” Continuing our exclusive insights into these five projects, in this interview we speak with Pekka Kahri and Nea Hellman (HUS Helsinki University Hospital) to learn more about the ONCOVALUE project, which employs RWD and AI-based tools to assess the effectiveness of novel cancer therapies in real-time. The project focuses on real-world hospital data for...

To view this content, please register now for access

It's completely free